Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Sulis Therapeutics ApS
APS
Active
Reklamebeskyttelse
CVR 44445832
Ole Maaløes Vej 3, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2023 · 2 years old
2 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Sulis Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
-1M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
-1M
-100%
2025
Income statement
DKK thousands
Item
2023
2024
2025
Gross profit
-2
-167
-866
Staff expenses
-0
-28
-97
EBITDA
-2
-195
-964
Depreciation & amort.
-3
-30
-30
EBIT
-5
-225
-994
Net financials
0
-11
-53
Profit before tax
-5
-236
-1.047
Tax
-0
-34
-154
Net profit
-5
-202
-893
Balance sheet
DKK thousands
Item
2023
2024
2025
Total assets
196
533
1.505
Equity
156
-46
-939
Long-term debt
0
546
2.078
Short-term debt
40
33
365
Total debt
40
579
2.443
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-96355800.0%
This company
2023
2025
Soliditetsgrad
-62.4%
This company
38.2%
Market median
-263% vs market
2023
2025
Egenkapitalforrentning
-89268700.0%
This company
18.4%
Market median
-485156078% vs market
2023
2025
Nettoresultatgrad (af bruttofortjeneste)
-89268700.0%
This company
2023
2025
Aktivomsætning (af bruttofortjeneste)
-0.58×
This company
2023
2025
Gæld/egenkapital
2.60×
This company
0.62×
Market median
-319% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-11-21 – 2023-12-31
View
PDF
More on Sulis Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
